Literature DB >> 10233406

Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype.

K Tsukasaki1, Y Imaizumi, M Tawara, T Fujimoto, T Fukushima, T Hata, T Maeda, Y Yamada, S Kamihira, M Tomonaga.   

Abstract

To investigate the diversity of morphology in adult T-cell leukaemia/lymphoma (ATL) and its possible association with the pathophysiology of ATL, we selected 36 acute cases and 14 chronic cases phenotypically confirmed to have >90% ATL cells in peripheral blood mononuclear cells. Prototype ATL cells were observed in all cases, although the percentage of all lymphoid cells varied considerably (48.9 +/- 23.8 in acute type, 29.6 +/- 18.9 in chronic type; P = 0.015). Chronic lymphocytic leukaemia (CLL)-like morphology with round nuclei was more frequent in chronic type than in acute type (52.0 +/- 24.9% v 16.6 +/- 13.1%; P < 0.0001). Unusual morphology (UM; lymphoblastic, vacuolated, granular pleomorphic or large cells) was more frequent in acute type than in chronic type (20.1 +/- 18.7% v 2.7 +/- 3.2%; P < 0.0001). Furthermore, there were significant negative and positive correlations of % CLL-like cells and % UM cells respectively, with serum LDH level, hypercalcaemia, performance status, and total number of involved lesions. Cases with aberrant immunophenotype (n = 6) or defective HTLV-1 integration (n = 22) showed lower % CLL-like cells and higher % UM cells than other cases, respectively. Cases with >50% CLL-like cells (n = 7; all chronic type) were younger (53.1 +/- 12.2 v 66.9 +/- 10.6 years; P = 0.038) and showed longer acute-crisis free survival (mean: 16.7 v 3. 0 years; P = 0.012) than chronic cases with <50% CLL-like cells. These results suggest that diversity in genotype, phenotype, morphology and behaviour of ATL are closely associated, and that CLL-like morphology is a good prognostic factor for chronic type.

Entities:  

Mesh:

Year:  1999        PMID: 10233406     DOI: 10.1111/j.1365-2141.1999.01323.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma.

Authors:  Andrew Hodson; Daniel J Laydon; Barbara J Bain; Paul A Fields; Graham P Taylor
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

2.  Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice.

Authors:  Devra D Huey; Brad Bolon; Krista M D La Perle; Priya Kannian; Steven Jacobson; Lee Ratner; Patrick L Green; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

3.  Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.

Authors:  Dandan Li; Qingwei Meng; Huijuan Zhang; Ting Feng; Meiyan Liu; Li Cai
Journal:  Tumour Biol       Date:  2015-10-24

4.  Adult T-Cell Leukemia/Lymphoma with CLL-Like Morphology-A Case Report.

Authors:  Nishant Tageja; Mobayed Mohammad; Gail Bentley; Carter Bishop
Journal:  Case Rep Med       Date:  2010-03-24

5.  Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.

Authors:  Kunihiro Tsukasaki; Olivier Hermine; Ali Bazarbachi; Lee Ratner; Juan Carlos Ramos; William Harrington; Deirdre O'Mahony; John E Janik; Achiléa L Bittencourt; Graham P Taylor; Kazunari Yamaguchi; Atae Utsunomiya; Kensei Tobinai; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

6.  Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.

Authors:  Seiichiro Kobayashi; Eri Watanabe; Tomohiro Ishigaki; Nobuhiro Ohno; Koichiro Yuji; Kazumi Nakano; Tadanori Yamochi; Nobukazu Watanabe; Arinobu Tojo; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Cancer Sci       Date:  2015-03-20       Impact factor: 6.716

7.  Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

Authors:  Hiromu Yano; Yukio Fujiwara; Hasita Horlad; Chang Pan; Keitaro Kai; Daisuke Niino; Kumiko Ohsawa; Morihiro Higashi; Kisato Nosaka; Yutaka Okuno; Jun-Ichi Tamaru; Akitake Mukasa; Masao Matsuoka; Yoshihiro Komohara
Journal:  Cancer Sci       Date:  2022-04-08       Impact factor: 6.518

Review 8.  Current status of therapeutic approaches to adult T-cell leukemia.

Authors:  Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.319

9.  Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.

Authors:  Mohammad Mehdi Akbarin; Hossein Rahimi; Tahereh Hassannia; Ghazaleh Shoja Razavi; Faezeh Sabet; Abbas Shirdel
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.